
Nalu Bio is a biotech unlocking the therapeutic potential of the endocannabinoid system with AI-driven chemistry to develop ultra-pure, non-intoxicating cannabinoid-based ingredients and targeted therapeutics for health and wellness, offering scalable, predictable, and science-backed solutions.

Investment Details
Funding Round
Seed
Milestones
Funded in 2021

About the Founder
Caitlyn Krebs
Caitlyn Krebs is a commercial entrepreneur with 20+ years of healthcare management and a passion for building companies at the intersection of science and technology—from diabetes, Alzheimer’s, and cancer to machine learning and AI. At the forefront of 50+ B2B deals, she is focused on commercializing new products and technologies. Raised in Hawaii, she is the mom to two boys and avid Cross-fitter. BS in biology from Brown University.
Real Investors. Real Outcomes.
Start Your Investing Journey with Portfolia
Our live overview sessions are the best way to experience how Portfolia is transforming venture capital and why the experience is unmatched.
- MEET OUR PARTNERS
- LEARN HOW OUR FUNDS WORK
- SEE THE COMPANIES WE'RE BACKING.


